Jul 24, 2017 8:30 am EDT iBio, Inc. Enters into Common Stock Purchase Agreement for Up to $16.0 Million with Lincoln Park Capital
Jun 5, 2017 8:30 am EDT iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference
Jan 27, 2017 8:30 am EST Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action